Live Breaking News & Updates on Capital International Sarl
Stay updated with breaking news from Capital international sarl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Capital International Sarl lifted its stake in Freeport-McMoRan Inc. (NYSE:FCX – Free Report) by 29.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 187,597 shares of the natural resource company’s stock after buying an additional 42,998 shares during the period. Capital International […] ....
Capital International Sarl reduced its holdings in Armstrong World Industries, Inc. (NYSE:AWI – Free Report) by 2.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 31,119 shares of the construction company’s stock after selling 832 shares during the quarter. Capital International Sarl owned approximately […] ....
Capital International Sarl lifted its stake in shares of Block, Inc. (NYSE:SQ – Free Report) by 7.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 50,436 shares of the technology company’s stock after purchasing an additional 3,312 shares during the period. Capital International Sarl’s holdings in Block were worth $3,901,000 at the end of […] ....
Capital International Sarl lifted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 19.4% in the fourth quarter, HoldingsChannel reports. The firm owned 69,414 shares of the biopharmaceutical company’s stock after buying an additional 11,255 shares during the period. Capital International Sarl’s holdings in Gilead Sciences were worth $5,623,000 at the end of […] ....
Capital International Sarl raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 30,222 shares of the company’s stock after buying an additional 863 shares during the period. Capital International Sarl’s holdings in AbbVie were worth $4,684,000 at the end of […] ....